Leonie Strobbe
Leonie Strobbe publishes mostly in Pathology and Forensic Medicine, Hematology and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Cancer Genomics and Diagnostics.
- World rank
- #4,012,451 of 7,710,434 ranked researchers
- Rank in Netherlands
- #76,740 of 107,149
- Works
- 22
- Citations
- 155
- Citations per work
- 7.0
What does Leonie Strobbe research?
Leonie Strobbe's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1253.2%
- Medicine1253.2%
- Everything else733.8%
- Life Sciences313.0%
- 1Pathology and Forensic Medicine18% of their works
- 2Hematology13% of their works
- 3Oncology13% of their works
- 4Genetics10% of their works
- 5Cancer Research6% of their works
- 6Molecular Biology6% of their works
Research topics
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Cancer Genomics and Diagnostics
- Chronic Lymphocytic Leukemia Research
- CNS Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Chemotherapy-induced cardiotoxicity and mitigation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Leonie Strobbe's research?
The keywords of their largest research topics: Lymphoma, Rituximab, Classification, Molecular Profiling, Chemotherapy, Prognostic Scoring System, Diagnosis Criteria and International Myeloma Working Group.
- Myelofibrosis
- Doxorubicin
- Radiotherapy
- Mutational Signatures
- Chronic Lymphocytic Leukemia
- Cancer Genomics
- International Myeloma Working Group
- Prognostic Scoring System
- Molecular Profiling
- Rituximab
- Lymphoma
- Classification
- Chemotherapy
- Diagnosis Criteria
- CAR T Cells
- Chimeric Antigen Receptor
- Genomic Aberrations
- Primary CNS Lymphoma
- Anthracyclines
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Lymphoma132 topics
- Rituximab132 topics
- Classification101 topic
- Molecular Profiling101 topic
- Chemotherapy52 topics
- Prognostic Scoring System52 topics
- Diagnosis Criteria41 topic
- International Myeloma Working Group41 topic
- CAR T Cells31 topic
- Cancer Genomics31 topic
- Chimeric Antigen Receptor31 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Mutational Signatures31 topic
- Primary CNS Lymphoma31 topic
- Radiotherapy31 topic
- Anthracyclines21 topic
- Doxorubicin21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
Where does Leonie Strobbe work?
Leonie Strobbe's main affiliation in the publication record is Gelre Hospitals, Netherlands.
How many publications and citations does Leonie Strobbe have?
OpenAlex counts 22 works and 155 citations for Leonie Strobbe, an h-index of 6, ranking #4,012,451 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Leonie Strobbe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.